Switching HIV Drugs or Adding Zoledronic Acid Can Rebuild Bone Lost to Tenofovir
Audio narration · Coming soon
This announcement addresses the clinical concern of bone mineral density loss associated with tenofovir (TDF) use in HIV treatment. It highlights that switching HIV drugs or adding zoledronic acid may help recover bone lost due to TDF exposure.
Why this matters
PRISM scored this story 60/100 for interest.
Originally published by gnews